Liver Cirrhosis Diagnostic Tests Market to Expand with Significant CAGR by 2030

May 25, 2021

Liver Cirrhosis Diagnostic Tests: Introduction

Liver cirrhosis, also called hepatic cirrhosis, is a progressive chronic medical condition characterized by the development of scar tissues in replacement with healthy liver tissues
In liver cirrhosis, healthy liver tissues are destroyed and replaced by scar tissue, and the condition starts blocking of blood flow through the liver
Liver cirrhosis is primarily caused by underlying liver diseases such as hepatitis, fatty liver disease, toxic metals, and excessive alcoholism
Symptoms of liver cirrhosis do not appear in the primary stages of the disease; however, the normal functioning of the liver is affected as the disease progresses, leading to the exhibition of symptoms. The common symptoms of liver cirrhosis include loss of appetite, weight loss, visibility of blood capillaries on the skin and upper abdomen, pain in the abdomen, and nausea.
Diagnosis of liver disease is carried out by various tests, which includes blood tests, imaging tests, biopsy tests, and endoscopy tests

Request a sample to get extensive insights into the Liver Cirrhosis Diagnostic Tests Market

Liver Cirrhosis Diagnostic Tests Market: Key Drivers

High prevalence and rise in incidence of liver disorders such as hepatitis, fatty liver disease, and excessive alcoholism across the globe are key factors driving the liver cirrhosis diagnostic tests market
For instance, around 2 billion people across the globe are estimated to have either had or currently living with some form of hepatitis viral infection. According to World Health Organization, in 2016 around 399,000 people died worldwide due to hepatitis C, liver cirrhosis, and hepatocellular carcinoma.
Technological advancements in diagnostic tools, such biopsy tests, imaging tests, and endoscopic tests and a rise in the demand for liver cirrhosis tests are estimated to contribute to propel the market during the forecast period
High cost of imaging tests and lack of skilled professionals in low and middle income countries are likely to restrain the market during the forecast period

Liver Biopsy Tests Segment to be Highly Attractive

In terms of tests, the global market can be segmented into blood tests, biopsy tests, and imaging tests. The liver biopsy tests segment is projected to dominate the global market during the forecast period.
Liver biopsy tests involve extraction of a tissue sample from the liver for clinical examination. The liver biopsy procedure is usually performed by fine needle aspiration using endoscopic ultrasound for the detailed examination liver.
The biopsy test is considered as the gold standard as this technique helps detect a wide range of liver diseases without the need for repeated samplings. Moreover, easy sampling and diagnosis owing to technological advancements have led to the wide acceptance of this test among end-users

Diagnostic Laboratories to be Highly Attractive Segment

Based on end-user, the global liver cirrhosis diagnostics tests market can be classified into hospitals, diagnostic laboratories, and academic and research institutes. The diagnostic laboratories segment is projected to dominate the global market during the forecast period.
Presence of a large numbers of diagnostic laboratories, easy availability and accessibility of test at these centers, and low cost are major factors that are likely to drive the diagnostic laboratories segment in the near future
Rapid increase in the number of diagnostic laboratories in emerging economies, such as South Korea, India, China and Brazil, and foreign direct investments in diagnostic laboratories are factors that are likely to offer significant opportunity for expansion of the segment of the market during the forecast period.

Asia Pacific Liver Cirrhosis Diagnostics Market to Expand Rapidly

In terms of region, the global liver cirrhosis diagnostics market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America is likely to dominate the global market during the forecast period. High prevalence of hepatitis and fatty liver disease and rise in geriatric population are key factors that are expected to boost the market in the region during the forecast period.
The liver cirrhosis diagnostics market in Asia Pacific is anticipated to expand at a notable CAGR during the forecast period. Rapid expansion of the market in the region can be ascribed to a rise in incidence rate of hepatitis disease and excessive alcoholism in densely populated countries, such as India and China, and improvement of healthcare infrastructure in the region.
Significant expansion of the healthcare industry, easy access to healthcare facilities, and increase in investments in healthcare by leading players in Asia Pacific are expected to fuel the market in the region in the near future

To understand how our report can bring difference to your business strategy, Ask for a brochure

Key Players Operating in Global Liver Cirrhosis Diagnostics Tests Market

Global Liver Cirrhosis Diagnostics Tests Market: Research Scope

Global Liver Cirrhosis Diagnostics Tests Market, by Tests

Global Liver Cirrhosis Diagnostics Tests Market, by End User

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453